The FDA provides update on Essure postmarket review study as company prepares to halt sales of the device on December 31.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to strengthen the long-term safety oversight of the Essure device following discontinuation of its U.S. sales